Patterson Companies, Inc.

LSE:0KGB Stock Report

Market Cap: US$2.7b

Patterson Companies Valuation

Is 0KGB undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0KGB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0KGB ($30.88) is trading below our estimate of fair value ($53.77)

Significantly Below Fair Value: 0KGB is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0KGB?

Key metric: As 0KGB is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0KGB. This is calculated by dividing 0KGB's market cap by their current earnings.
What is 0KGB's PE Ratio?
PE Ratio17.6x
EarningsUS$155.22m
Market CapUS$2.73b

Price to Earnings Ratio vs Peers

How does 0KGB's PE Ratio compare to its peers?

The above table shows the PE ratio for 0KGB vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average29.2x
MDC Mediclinic International
21.9x10.7%UK£3.7b
SPI Spire Healthcare Group
31.8x26.9%UK£900.5m
CVSG CVS Group
22.8x15.5%UK£597.6m
EMIS EMIS Group
40.4x11.0%UK£1.2b
0KGB Patterson Companies
17.6x13.0%US$2.7b

Price-To-Earnings vs Peers: 0KGB is good value based on its Price-To-Earnings Ratio (17.6x) compared to the peer average (27.3x).

Price to Earnings Ratio vs Industry

How does 0KGB's PE Ratio compare vs other companies in the European Healthcare Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
0KGB 17.6xIndustry Avg. 18.0xNo. of Companies8PE01020304050+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0KGB is good value based on its Price-To-Earnings Ratio (17.6x) compared to the European Healthcare industry average (18x).

Price to Earnings Ratio vs Fair Ratio

What is 0KGB's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0KGB PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio17.6x
Fair PE Ratio35.1x

Price-To-Earnings vs Fair Ratio: 0KGB is good value based on its Price-To-Earnings Ratio (17.6x) compared to the estimated Fair Price-To-Earnings Ratio (35.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0KGB forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$30.88
US$29.68
-3.9%
10.4%US$31.35US$23.00n/a10
Dec ’25US$21.47
US$26.30
+22.5%
8.5%US$30.00US$22.00n/a10
Nov ’25US$21.08
US$26.30
+24.8%
8.5%US$30.00US$22.00n/a10
Oct ’25US$21.23
US$26.40
+24.4%
7.8%US$30.00US$23.00n/a10
Sep ’25US$22.40
US$26.70
+19.2%
7.1%US$30.00US$23.00n/a10
Aug ’25US$25.52
US$28.30
+10.9%
6.7%US$31.00US$25.00n/a10
Jul ’25US$24.10
US$28.64
+18.8%
5.6%US$31.00US$26.00n/a11
Jun ’25US$24.41
US$29.27
+19.9%
5.8%US$32.00US$26.00n/a11
May ’25US$25.49
US$29.73
+16.6%
6.4%US$34.00US$27.00n/a11
Apr ’25US$28.02
US$29.82
+6.4%
6.0%US$34.00US$28.00n/a11
Mar ’25US$27.03
US$29.91
+10.7%
6.1%US$34.00US$28.00n/a11
Feb ’25US$29.94
US$31.00
+3.5%
6.9%US$35.00US$28.00n/a10
Jan ’25US$28.06
US$31.00
+10.5%
9.0%US$37.00US$27.00n/a10
Dec ’24US$26.49
US$31.70
+19.7%
8.9%US$37.00US$27.00US$21.4710
Nov ’24US$30.03
US$35.10
+16.9%
8.1%US$40.00US$32.00US$21.0810
Oct ’24US$29.75
US$35.50
+19.3%
7.5%US$40.00US$32.00US$21.2310
Sep ’24US$30.42
US$35.73
+17.4%
7.4%US$40.00US$32.00US$22.4011
Aug ’24US$33.37
US$35.18
+5.4%
8.5%US$40.00US$31.00US$25.5211
Jul ’24US$33.33
US$35.18
+5.6%
8.5%US$40.00US$31.00US$24.1011
Jun ’24US$26.42
US$31.59
+19.6%
9.6%US$36.00US$27.50US$24.4111
May ’24US$26.46
US$31.59
+19.4%
9.6%US$36.00US$27.50US$25.4911
Apr ’24n/a
US$31.59
0%
9.6%US$36.00US$27.50US$28.0211
Mar ’24US$28.26
US$32.50
+15.0%
8.7%US$37.00US$29.00US$27.0311
Feb ’24US$30.06
US$32.95
+9.6%
11.4%US$42.00US$29.00US$29.9411
Jan ’24US$28.15
US$33.05
+17.4%
11.3%US$42.00US$29.00US$28.0611
Dec ’23US$29.13
US$32.32
+11.0%
11.6%US$39.00US$26.00US$26.4911

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 15:10
End of Day Share Price 2024/12/20 00:00
Earnings2024/10/26
Annual Earnings2024/04/27

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Patterson Companies, Inc. is covered by 37 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jeffrey JohnsonBaird
Lawrence MarshBarclays
Charley JonesBarrington Research Associates, Inc.